Skip to main content
. 2020 May-Jun;35(3):307–313. doi: 10.21470/1678-9741-2019-0144

Table 2.

Operative and postoperative outcomes.

  No OA (N=61) OA (N=42) P-value
CPB time (min) (SD) 104 (45) 103 (34) 0.934
AXC time (min) (SD) 76 (32) 79 (31) 0.721
Prosthesis size (mm) (SD) 21.7 (1.8) 21.6 (1.9) 0.596
Prosthesis (%)     0.457
St Jude Epic 29 (47.5) 22 (52.4)  
Mosaic 9 (14.8) 4 (9.5)  
Mitroflow 2 (3.3) 0  
Hancock II 16 (26.2) 14 (33.3)  
Braile 3 (4.9) 0  
CE-Perimount 2 (3.3) 2 (4.8)  
MVR (%) 0 5 (11.9) 0.006*
Use of RBC (%) 4 (6.6) 6 (14.3) 0.193
Extended inotrope use (%) 38 (62.3) 24 (57.1) 0.6
Stroke (%) 3 (4.9) 1 (2.4) 0.513
TIA (%) 8 (13.1) 2 (4.8) 0.159
AVB (%) 6 (9.8) 3 (7.1) 0.634
Pacemaker (%) 2 (3.3) 0 (0) 0.236
ICU stay (days) (SD) 3.8 (4.2) 2.7 (2.9) 0.153
MVS (hours) (SD) 16.2 (20.4) 15.5 (17.9) 0.862
Bleeding (ml)(SD) 954 (816) 691 (577) 0.058

AVB=atrioventricular block; AXC=aortic cross-clamp; CE=Carpentier Edwards; CPB=cardiopulmonary bypass; ICU=intensive care unit; MVR=mitral valve replacement; MVS=mechanical ventilatory support; OA=oral anticoagulation; RBC=red blood cells; SD=standard deviation; TIA=transient ischemic attack.

*

P<0.05.